FDA Grants Rare Pediatric Disease Designation to WP1066 for Ependymoma
OncLive,
The FDA has granted a rare pediatric disease (RPD) designation to the p-STAT3 inhibitor WP1066 for the treatment of patients…
The FDA has granted a rare pediatric disease (RPD) designation to the p-STAT3 inhibitor WP1066 for the treatment of patients…
The FDA has approved the request submitted by Moleculin Biotech, Inc. for rare disease designations to be granted their drug…